Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neutropenia|Breast Cancer
Interventions: BIOLOGICAL: F-627|DRUG: EC regimen
Sponsor: EVIVE Biotechnology
Collaborators: Fudan University